Spondylarthropathies juvéniles : quels outils d’évaluation ? Quand débuter un traitement anti-TNF-α ?

Petty, 2004, International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001, J Rheumatol, 31, 390 Garrett, 1994, A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, 21, 2286 Calin, 1994, A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index, J Rheumatol, 21, 2281 Jenkinson, 1994, Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index, J Rheumatol, 21, 1694 Calin, 1999, A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index, J Rheumatol, 26, 988 Giannini, 1997, Preliminary definition of improvement in juvenile arthritis, Arthritis Rheum, 40, 1202, 10.1002/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R Wallace, 2011, American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis, Arthritis Rheum, 63, 929, 10.1002/acr.20497 Viola, 2005, Development and validation of a clinical index for assessment of long terme damage in juvenile idiopathic arthritis, Arthritis Rheum, 52, 2092, 10.1002/art.21119 Sarma, 2008, Outcome in patients with enthesitis related arthritis: JADI and functional status, Paediatr Rheumatol, 6, 18, 10.1186/1546-0096-6-18 Coulton, 1987, Assessment of the reliability and validity of the arthritis impact measurement scales for children with juvenile arthritis, Arthritis Rheum, 30, 819, 10.1002/art.1780300713 Lovell, 1989, Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Scale, Arthritis Rheum, 32, 1390, 10.1002/anr.1780321107 Wright, 1994, Development of a self-report functional status index for juvenile rheumatoid arthritis, J Rheumatol, 21, 536 Duffy, 1997, The Juvenile Arthritis Quality of Life Questionnaire – development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides, J Rheumatol, 24, 738 Singh, 1994, Measurement of health status in children with juvenile rheumatoid arthritis, Arthritis Rheum, 37, 1761, 10.1002/art.1780371209 Pouchot, 2002, Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis, Joint Bone Spine, 65, 468, 10.1016/S1297-319X(02)00432-3 Henrickson, 2004, Prolonged efficacy of etanercept in refractory enthesitis-related arthritis, J Rheumatol, 31, 2055 Sulpice, 2009, Efficacy and safety of TNF-alpha anagonist therapy in patients with juvenile spondyloarthropathies, Joint Bone Spine, 76, 24, 10.1016/j.jbspin.2008.03.008 Tse, 2005, Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy, Arthritis Rheum, 52, 2103, 10.1002/art.21121 Otten, 2011, Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis - date from the Dutch arthritis and biologicals in children register 1999-2010, J Rheum, 38, 10, 10.3899/jrheum.110145 Pham, 2007, Recommendations of the French Society for Rheumatology regarding TNF alpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis. Club Rhumatismes et Inflammation (CRI/SFR), Joint Bone Spine, 74, 638, 10.1016/j.jbspin.2007.10.003